Stay updated on Nivolumab Plus ABI-009 in Sarcoma: Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Plus ABI-009 in Sarcoma: Clinical Trial page.

Latest updates to the Nivolumab Plus ABI-009 in Sarcoma: Clinical Trial page
- CheckyesterdayChange DetectedNo significant content changes observed on the Study Details page; the study information and sections remain consistent across screenshots. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check8 days agoChange DetectedAdded a Locations section listing California as a study site (Santa Monica). The footer now shows Revision: v3.3.3 and removes the HHS Vulnerability Disclosure link, with 'California Locations' phrasing adjusted.SummaryDifference0.3%

- Check15 days agoChange DetectedA Study Results section has appeared, listing results and related publications, including a 'Results First Posted' date of 2025-02-17. Study Record Dates have been updated to reflect these results posting.SummaryDifference0.1%

- Check22 days agoChange DetectedNo substantive changes are visible between the two screenshots of the Study Details page; content and layout appear consistent.SummaryDifference0.1%

- Check37 days agoChange DetectedAdded notes that publications are voluntarily provided and may be about the study results, and that publications are automatically filled in from PubMed; included a revision tag Revision: v3.3.2. Removed older wording stating that publications come from PubMed and are automatically created by ClinicalTrials.gov with an NCT number, which corresponds to Revision: v3.2.0.SummaryDifference0.3%

- Check44 days agoChange DetectedA government funding/operating status banner was removed from the page, leaving the core study information intact. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Nivolumab Plus ABI-009 in Sarcoma: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus ABI-009 in Sarcoma: Clinical Trial page.